Anti-CD248 molecule antibodies are used for the immunodetection of the protein encoded by the CD248 gene. In humans, the canonical protein has a reported length of 757 amino acid residues and a mass of 80.9 kDa. Its subcellular localization is in the membrane. Alternative splicing is reported to yield 2 different isoforms for this protein. It is reported to be expressed in tumor endothelial cells but absent or barely detectable in normal endothelial cells. It is believed to play a role in tumor angiogenesis. Post-translational modifications have been described, including O-glycosylation and N-glycosylation. Other names for this target antigen include 2610111G01Rik, CD164 sialomucin-like 1, CD248 antigen, endosialin, CD248 molecule, endosialin, tumor endothelial marker 1, and endosialin. Gene orthologs have been identified in the mouse, rat, bovine, frog and chimpanzee species. A number of CD248 molecule antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. ELISA, Immunofluorescence, and Immunohistochemistry are also common applications.